Moxiclav Bis (Amoxicillin, Clavulanic Acid)

Amoxicillin, the active ingredient in Moxiclav Bis, is a beta‑lactam antibiotic presented as a tablet for oral use. It treats bacterial infections such as sinusitis, pneumonia, otitis media, urinary tract infections and skin infections in adults and children.

GNH USA supplies Moxiclav Bis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxiclav Bis is indicated for bacterial infections affecting the respiratory, ear, urinary and skin systems.

- Sinusitis: reduces bacterial load and relieves sinus inflammation. - Pneumonia: eradicates the causative pathogens and improves lung function. - Otitis media: clears middle‑ear infection and diminishes pain. - Urinary tract infection: eliminates uropathogens and resolves urinary symptoms. - Skin and soft‑tissue infection: treats cellulitis and other bacterial skin conditions.

Adverse reactions may occur with any antibiotic therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: increased bowel movements, sometimes loose. - Vomiting: occasional emesis after dosing. - Abdominal pain: cramping or discomfort. - Rash: mild skin erythema or itching. - Taste disturbance: altered taste perception.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Clostridioides difficile‑associated diarrhea: severe colitis after disruption of gut flora. - Hepatic enzyme elevation: increased ALT/AST indicating liver stress. - Neutropenia: reduced neutrophil count, increasing infection risk. - Stevens‑Johnson syndrome: severe mucocutaneous blistering. - Serum sickness‑like reaction: fever, arthralgia, rash after exposure.

Before prescribing Moxiclav Bis, clinicians should consider the following precautions.

- Renal impairment: dose adjustment may be required in reduced kidney function. - Hepatic disease: monitor liver enzymes during therapy. - History of penicillin allergy: avoid use in patients with documented hypersensitivity. - Pregnancy and lactation: evaluate risk‑benefit ratio before prescribing. - Concomitant oral contraceptives: efficacy may be decreased, advise additional contraception. - Store at ambient temperature: keep in the original pack, protect from moisture.

Moxiclav Bis can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Probenecid: may increase amoxicillin plasma concentrations leading to toxicity. - Methotrexate: reduced clearance can cause severe toxicity. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Allopurinol: increased incidence of rash. - Oral contraceptives: may reduce hormonal efficacy.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxic potential. - Anticoagulants: monitor INR or PT when co‑administered. - Diuretics: watch electrolyte balance, especially potassium. - Antacids containing aluminum or magnesium: may impair amoxicillin absorption. - Live vaccines: possible reduction in vaccine effectiveness.